Medicines Australia announces new Advisory Council Members
Medicines Australia is pleased to announce that Dr Leigh Farrell, Ms Kelly Constable, Mr Greg Allen, Mr David Norton and Ms Jane Hill will be joining other key health and pharmaceutical industry leaders on the Medicines Australia Advisory Council.
Established in 2017, the Advisory Council is charged with providing strategic advice and perspectives that broaden and enhance the Board’s strategic discussions about the future direction of the Australian innovative pharmaceutical industry.
Medicines Australia Chair, Dr Anna Lavelle thanked the current Advisory Council for their valuable insights and expertise and acknowledged their contribution to matters of national policy import, such as the National Medicines Policy Review.
“Medicines Australia looks forward to participating fully in this Review, due to commence shortly, and has already contributed to designing its terms of reference, with the assistance of the Council.
“The new 2020 Advisory Council members are all talented and highly regarded in their fields. They form part of a team that brings together a diverse range of experiences, from different facets of our industry and the broader health ecosystem” said Dr Lavelle.
Dr Leigh Farrell, Non-Executive Director, Pro Medicus Ltd, is an experienced company Director who also has extensive global senior leadership experience. This experience enables Leigh to probe key matters of corporate governance, strategy and risk as they relate to the role of the Medicines Australia Board.
Kelly Constable, Chief Strategy Officer at Australian Genomic Cancer Medicine (OMICO LTD) is an experienced pharmaceutical leader. Having previously having worked for Amgen as a senior leader at the company’s headquarters in Thousand Oaks, California, Kelly has spent the past 12 months dedicated to the evolution of genomics in oncology clinical trial design and software tools for point of care genomics.
Greg Allen is the Finance Manager at Epworth Freemasons Hospital. Issues of particular professional interest for Greg currently include financial sustainability and innovation in Private Healthcare (particularly now in a post-COVID environment), excellence in customer service and the patient experience, and development of health management skills in mid-level clinical managers and clinicians.
Jane Hill is the Non-Executive Director of the World Ovarian Cancer Coalition and Chair of the Patients Advocacy Alliance. Jane is passionate about creating a health system that puts the consumer first. Her areas of expertise span health, youth, women, indigenous and rural and remote health. Jane has a strong affiliation and understanding of issues affecting rural Australia.
David Norton, until his retirement in September 2011, was Company Group Chairman, Global Pharmaceuticals for Johnson & Johnson. In this position he was responsible for leading and developing the strategic growth agenda, including the strategy for licensing, acquisitions and divestments, and ensuring alignment with the global strategic functions, R&D and the Commercial organisations.
“Our industry is facing huge disruption due to the COVID-19 pandemic and the sector is playing an essential role in the recovery of our economy. As a nation we have learnt that a healthy economy is only possible when we have a healthy community,” said Dr Lavelle
“To have such extensive knowledge and experience on our Advisory Council at this crucial time is testament to the importance of this industry and the value the sector brings to society,” said Dr Lavelle.
“On behalf of the Board of Medicines Australia I am delighted to announce the following members of the 2020-2022 Advisory Council:
Mr Greg Allen FCHSM CHE (Independent Member)
Mr Andrew Carter FAICD (Member Company Member)
Prof. Ian Chubb AC FAA (Independent Member)
Ms Kelly Constable (Independent Member)
Dr Leigh Farrell, FAICD (Independent Member)
Dr Jeff Harmer AO (Independent Member)
Ms Jane Hill FAICD (Independent Member)
Mr David Norton (Independent Member)
Ms Belinda Wood GAICD (Member Company Member)
- Ends –
More information – Natalie Wimmer – Media and Communications Manager, Medicines Australia – nwimmer@medaus.com.au 0450728660